Ascend Capital Group
VC Fund
Singapore, Singapore
Ascend Capital Group is a VC fund in Singapore focused on Mining and FinTech. Ascend Capital Group creates and executes public and private capital investment strategies for its investors with superior returns through value-added principles of investment.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 67%
Last updated:
For AI agents: llms.txt
Industries Ascend Capital Group invests in
Stages Ascend Capital Group invests in
Countries Ascend Capital Group invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Mining 1 (33%)
- FinTech 1 (33%)
- Mineral 1 (33%)
- Chemical 1 (33%)
- InsurTech 1 (33%)
Stage
- Series A 1 (33%)
- Private Equity 1 (33%)
- Post-IPO Equity 1 (33%)
Country
- Australia 1 (33%)
- Indonesia 1 (33%)
- United States 1 (33%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Eric Parekh
Managing Director
|
Managing Director | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| 5E Advanced Materials is a boron and lithium solution company. They provide services due to the scarcity of resources and reliance on an unstable international supply. Their customers' inquiries are addressed through phone, email, and online applications. | $6.6M / Post-IPO Equity / Jan 19, 2024 | ||
| FUNDtastic is an online investment platform. Is an easy and safe way to buy and sell mutal funds, gold and other investment instruments. | $7.7M / Series A / Feb 22, 2021 | ||
| Prometheus Biosciences, Inc., former Prometheus Laboratories, Inc., a specialty pharmaceutical company, engages in developing and commercializing novel pharmaceutical and diagnostic products to help physicians individualize patient care. It markets and promotes Entocort EC, a glucocorticosteroid, which is indicated for the induction and maintenanceof clinical remission in mild to moderately active Crohn's disease involving the ileum and/or the ascending colon. It has an agreement to acquire rights to LOTRONEX tablets, which is used in female patients with diarrhea-predominant irritable bowel syndrome; and an agreement to develop and commercialize COLAL-PRED, a development-stage product for the treatment of gastrointestinal diseases or other applications. The company also sells other branded drugs, including Imuran for use as an adjunct for the prevention of rejection in kidney transplantation and the management of active rheumatoid arthritis, Helidac Therapy for use together with an H2 antagonist for the eradication of helicobacter pylori bacteria, and Ridaura for the management of rheumatoid arthritis. In addition, Prometheus Laboratories sells a generic formulation of mercaptopurine, which is approved as maintenance therapy for acute lymphatic leukemia as part of a combination regimen through third-party distributors. Further, it provides diagnostic testing services, including specific immunoassays to detect and differentiate diseases, pharmacogenetic testing, and drug metabolite monitoring; and tests that assist physicians in using and monitoring thiopurine drugs and the detection, diagnosis, or treatment of celiac disease, lactose intolerance, and other related disorders. Prometheus Laboratories, Inc. was founded in 1995 and is headquartered in San Diego, California. | $130M / Private Equity / Nov 09, 2020 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Ascend Capital Group invest in?
Ascend Capital Group invests primarily in Mining, FinTech and Mineral startups, most often at Series A and Private Equity stage. Most of the 3 investments tracked by Shizune back companies in Australia. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Ascend Capital Group?
Public channels for Ascend Capital Group include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Ascend Capital Group?
The team at Ascend Capital Group includes Eric Parekh (Managing Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Nov 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
